CANCER CELL-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=833222, encodeId=c5198332220d, content=要求比较严，英国人还是比较严谨，1270磅版面费，较贵，下次投个汇率低的国家。严格按照编辑意见及审稿人意见修改文章，应该较快，自己补充实验较慢，导致投稿时间较慢，历时10个月，自己浪费了3-5月，大修补充实验2次，小修5次。希望帮到大家。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=306, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=318b5414073, createdName=ms2466276523160074, createdTime=Fri Aug 19 12:01:15 CST 2016, time=2016-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=957032, encodeId=c03195e03209, content=南京鼓楼医院孙倍成教授今年联合国外学者发了一篇关于胰腺癌的文章，他是搞肝移植的啊！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=219, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/PiajxSqBRaEKbUQVcNicMmoEngbhNsjHtgPVly9ibpH1ngtTSp4EjBLr38AKWnRaGSJRVPTfjNL7rlfd969jibvZaw/132, createdBy=793b1668391, createdName=darktempler, createdTime=Wed Apr 14 19:50:27 CST 2021, time=2021-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2097331, encodeId=f648209e331a9, content=偏重的研究方向：肿瘤学;肿瘤 经验分享：集团队重点力量，耗时三年，肿瘤免疫领域，终于发表一篇该期刊。以往都是秒拒，难度还是相当大, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=135, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210104/1a4d3d11af7842afadd172a4a59b32f9/66b07e825e8e4455b5099c678c51e0c6.jpg, createdBy=ab332214260, createdName=susu2019, createdTime=Sat Oct 29 19:21:16 CST 2022, time=2022-10-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1091494, encodeId=38681091494e3, content=文章题目有没有撰写模板？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=204, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1091493, encodeId=29a51091493fd, content=撰写文章题目有没有技巧？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=205, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1009794, encodeId=2f231009e9412, content=请问这个提交之后，一般多久就知道要不要送审，还是直接拒掉, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=221, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b9562152670, createdName=132Luux9886, createdTime=Fri Aug 20 18:51:50 CST 2021, time=2021-08-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=558726, encodeId=597c558e268d, content=CNS子刊生物医学类里面最难的就是nature medicine和cancer cell 需要工作量而不是idea好就能支撑的审稿也很严格可以见到很多文章从received到accepted经历了两年多个人不建议投他家如果可以还不如先试试NCBsunliang 2018-06-30 发表:: 啥时候也来一篇呢.好杂志.不容错过, beContent=sunliang 2018-06-30 发表:: 啥时候也来一篇呢.好杂志.不容错过, objectType=tool_impact_factor, channel=null, level=null, likeNumber=591, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f8eb1668018, createdName=bigapple001, createdTime=Sun Jul 01 18:05:00 CST 2018, time=2018-07-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2197531, encodeId=4303219e5317e, content=都在发这杂志，一年几十篇，以后做科研没CC，不好混了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=44ce21017, createdName=lingtao-zd, createdTime=Tue Apr 09 09:18:30 CST 2024, time=2024-04-09, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2192348, encodeId=6f41219234868, content=With editor快20天了，请问有没有人走同样的经历？后面需要发邮件问一下吗🥹, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=780c5321661, createdName=Dr Young, createdTime=Sun Mar 10 10:33:22 CST 2024, time=2024-03-10, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1224059, encodeId=8d12122405991, content=18年投过一个被拒，20年打酱油发了一个。最近进入产出低潮。手头只有一个工作想冲击一下，可是疫情影响，很多事情耽误。希望下半年能做完投出去。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=190, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=4fed1686029, createdName=cindichaw, createdTime=Thu Jun 02 15:13:54 CST 2022, time=2022-06-02, status=1, ipAttribution=)]

2016-08-19 ms2466276523160074

要求比较严，英国人还是比较严谨，1270磅版面费，较贵，下次投个汇率低的国家。严格按照编辑意见及审稿人意见修改文章，应该较快，自己补充实验较慢，导致投稿时间较慢，历时10个月，自己浪费了3-5月，大修补充实验2次，小修5次。希望帮到大家。

306 6

展开6条回复

[GetPortalCommentsPageByObjectIdResponse(id=833222, encodeId=c5198332220d, content=要求比较严，英国人还是比较严谨，1270磅版面费，较贵，下次投个汇率低的国家。严格按照编辑意见及审稿人意见修改文章，应该较快，自己补充实验较慢，导致投稿时间较慢，历时10个月，自己浪费了3-5月，大修补充实验2次，小修5次。希望帮到大家。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=306, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=318b5414073, createdName=ms2466276523160074, createdTime=Fri Aug 19 12:01:15 CST 2016, time=2016-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=957032, encodeId=c03195e03209, content=南京鼓楼医院孙倍成教授今年联合国外学者发了一篇关于胰腺癌的文章，他是搞肝移植的啊！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=219, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/PiajxSqBRaEKbUQVcNicMmoEngbhNsjHtgPVly9ibpH1ngtTSp4EjBLr38AKWnRaGSJRVPTfjNL7rlfd969jibvZaw/132, createdBy=793b1668391, createdName=darktempler, createdTime=Wed Apr 14 19:50:27 CST 2021, time=2021-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2097331, encodeId=f648209e331a9, content=偏重的研究方向：肿瘤学;肿瘤 经验分享：集团队重点力量，耗时三年，肿瘤免疫领域，终于发表一篇该期刊。以往都是秒拒，难度还是相当大, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=135, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210104/1a4d3d11af7842afadd172a4a59b32f9/66b07e825e8e4455b5099c678c51e0c6.jpg, createdBy=ab332214260, createdName=susu2019, createdTime=Sat Oct 29 19:21:16 CST 2022, time=2022-10-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1091494, encodeId=38681091494e3, content=文章题目有没有撰写模板？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=204, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1091493, encodeId=29a51091493fd, content=撰写文章题目有没有技巧？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=205, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1009794, encodeId=2f231009e9412, content=请问这个提交之后，一般多久就知道要不要送审，还是直接拒掉, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=221, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b9562152670, createdName=132Luux9886, createdTime=Fri Aug 20 18:51:50 CST 2021, time=2021-08-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=558726, encodeId=597c558e268d, content=CNS子刊生物医学类里面最难的就是nature medicine和cancer cell 需要工作量而不是idea好就能支撑的审稿也很严格可以见到很多文章从received到accepted经历了两年多个人不建议投他家如果可以还不如先试试NCBsunliang 2018-06-30 发表:: 啥时候也来一篇呢.好杂志.不容错过, beContent=sunliang 2018-06-30 发表:: 啥时候也来一篇呢.好杂志.不容错过, objectType=tool_impact_factor, channel=null, level=null, likeNumber=591, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f8eb1668018, createdName=bigapple001, createdTime=Sun Jul 01 18:05:00 CST 2018, time=2018-07-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2197531, encodeId=4303219e5317e, content=都在发这杂志，一年几十篇，以后做科研没CC，不好混了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=44ce21017, createdName=lingtao-zd, createdTime=Tue Apr 09 09:18:30 CST 2024, time=2024-04-09, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2192348, encodeId=6f41219234868, content=With editor快20天了，请问有没有人走同样的经历？后面需要发邮件问一下吗🥹, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=780c5321661, createdName=Dr Young, createdTime=Sun Mar 10 10:33:22 CST 2024, time=2024-03-10, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1224059, encodeId=8d12122405991, content=18年投过一个被拒，20年打酱油发了一个。最近进入产出低潮。手头只有一个工作想冲击一下，可是疫情影响，很多事情耽误。希望下半年能做完投出去。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=190, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=4fed1686029, createdName=cindichaw, createdTime=Thu Jun 02 15:13:54 CST 2022, time=2022-06-02, status=1, ipAttribution=)]

2021-04-14 darktempler

南京鼓楼医院孙倍成教授今年联合国外学者发了一篇关于胰腺癌的文章，他是搞肝移植的啊！

219 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=833222, encodeId=c5198332220d, content=要求比较严，英国人还是比较严谨，1270磅版面费，较贵，下次投个汇率低的国家。严格按照编辑意见及审稿人意见修改文章，应该较快，自己补充实验较慢，导致投稿时间较慢，历时10个月，自己浪费了3-5月，大修补充实验2次，小修5次。希望帮到大家。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=306, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=318b5414073, createdName=ms2466276523160074, createdTime=Fri Aug 19 12:01:15 CST 2016, time=2016-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=957032, encodeId=c03195e03209, content=南京鼓楼医院孙倍成教授今年联合国外学者发了一篇关于胰腺癌的文章，他是搞肝移植的啊！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=219, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/PiajxSqBRaEKbUQVcNicMmoEngbhNsjHtgPVly9ibpH1ngtTSp4EjBLr38AKWnRaGSJRVPTfjNL7rlfd969jibvZaw/132, createdBy=793b1668391, createdName=darktempler, createdTime=Wed Apr 14 19:50:27 CST 2021, time=2021-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2097331, encodeId=f648209e331a9, content=偏重的研究方向：肿瘤学;肿瘤 经验分享：集团队重点力量，耗时三年，肿瘤免疫领域，终于发表一篇该期刊。以往都是秒拒，难度还是相当大, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=135, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210104/1a4d3d11af7842afadd172a4a59b32f9/66b07e825e8e4455b5099c678c51e0c6.jpg, createdBy=ab332214260, createdName=susu2019, createdTime=Sat Oct 29 19:21:16 CST 2022, time=2022-10-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1091494, encodeId=38681091494e3, content=文章题目有没有撰写模板？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=204, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1091493, encodeId=29a51091493fd, content=撰写文章题目有没有技巧？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=205, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1009794, encodeId=2f231009e9412, content=请问这个提交之后，一般多久就知道要不要送审，还是直接拒掉, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=221, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b9562152670, createdName=132Luux9886, createdTime=Fri Aug 20 18:51:50 CST 2021, time=2021-08-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=558726, encodeId=597c558e268d, content=CNS子刊生物医学类里面最难的就是nature medicine和cancer cell 需要工作量而不是idea好就能支撑的审稿也很严格可以见到很多文章从received到accepted经历了两年多个人不建议投他家如果可以还不如先试试NCBsunliang 2018-06-30 发表:: 啥时候也来一篇呢.好杂志.不容错过, beContent=sunliang 2018-06-30 发表:: 啥时候也来一篇呢.好杂志.不容错过, objectType=tool_impact_factor, channel=null, level=null, likeNumber=591, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f8eb1668018, createdName=bigapple001, createdTime=Sun Jul 01 18:05:00 CST 2018, time=2018-07-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2197531, encodeId=4303219e5317e, content=都在发这杂志，一年几十篇，以后做科研没CC，不好混了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=44ce21017, createdName=lingtao-zd, createdTime=Tue Apr 09 09:18:30 CST 2024, time=2024-04-09, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2192348, encodeId=6f41219234868, content=With editor快20天了，请问有没有人走同样的经历？后面需要发邮件问一下吗🥹, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=780c5321661, createdName=Dr Young, createdTime=Sun Mar 10 10:33:22 CST 2024, time=2024-03-10, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1224059, encodeId=8d12122405991, content=18年投过一个被拒，20年打酱油发了一个。最近进入产出低潮。手头只有一个工作想冲击一下，可是疫情影响，很多事情耽误。希望下半年能做完投出去。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=190, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=4fed1686029, createdName=cindichaw, createdTime=Thu Jun 02 15:13:54 CST 2022, time=2022-06-02, status=1, ipAttribution=)]

2022-10-29 susu2019

偏重的研究方向：肿瘤学;肿瘤
经验分享：集团队重点力量，耗时三年，肿瘤免疫领域，终于发表一篇该期刊。以往都是秒拒，难度还是相当大

135 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=833222, encodeId=c5198332220d, content=要求比较严，英国人还是比较严谨，1270磅版面费，较贵，下次投个汇率低的国家。严格按照编辑意见及审稿人意见修改文章，应该较快，自己补充实验较慢，导致投稿时间较慢，历时10个月，自己浪费了3-5月，大修补充实验2次，小修5次。希望帮到大家。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=306, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=318b5414073, createdName=ms2466276523160074, createdTime=Fri Aug 19 12:01:15 CST 2016, time=2016-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=957032, encodeId=c03195e03209, content=南京鼓楼医院孙倍成教授今年联合国外学者发了一篇关于胰腺癌的文章，他是搞肝移植的啊！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=219, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/PiajxSqBRaEKbUQVcNicMmoEngbhNsjHtgPVly9ibpH1ngtTSp4EjBLr38AKWnRaGSJRVPTfjNL7rlfd969jibvZaw/132, createdBy=793b1668391, createdName=darktempler, createdTime=Wed Apr 14 19:50:27 CST 2021, time=2021-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2097331, encodeId=f648209e331a9, content=偏重的研究方向：肿瘤学;肿瘤 经验分享：集团队重点力量，耗时三年，肿瘤免疫领域，终于发表一篇该期刊。以往都是秒拒，难度还是相当大, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=135, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210104/1a4d3d11af7842afadd172a4a59b32f9/66b07e825e8e4455b5099c678c51e0c6.jpg, createdBy=ab332214260, createdName=susu2019, createdTime=Sat Oct 29 19:21:16 CST 2022, time=2022-10-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1091494, encodeId=38681091494e3, content=文章题目有没有撰写模板？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=204, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1091493, encodeId=29a51091493fd, content=撰写文章题目有没有技巧？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=205, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1009794, encodeId=2f231009e9412, content=请问这个提交之后，一般多久就知道要不要送审，还是直接拒掉, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=221, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b9562152670, createdName=132Luux9886, createdTime=Fri Aug 20 18:51:50 CST 2021, time=2021-08-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=558726, encodeId=597c558e268d, content=CNS子刊生物医学类里面最难的就是nature medicine和cancer cell 需要工作量而不是idea好就能支撑的审稿也很严格可以见到很多文章从received到accepted经历了两年多个人不建议投他家如果可以还不如先试试NCBsunliang 2018-06-30 发表:: 啥时候也来一篇呢.好杂志.不容错过, beContent=sunliang 2018-06-30 发表:: 啥时候也来一篇呢.好杂志.不容错过, objectType=tool_impact_factor, channel=null, level=null, likeNumber=591, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f8eb1668018, createdName=bigapple001, createdTime=Sun Jul 01 18:05:00 CST 2018, time=2018-07-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2197531, encodeId=4303219e5317e, content=都在发这杂志，一年几十篇，以后做科研没CC，不好混了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=44ce21017, createdName=lingtao-zd, createdTime=Tue Apr 09 09:18:30 CST 2024, time=2024-04-09, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2192348, encodeId=6f41219234868, content=With editor快20天了，请问有没有人走同样的经历？后面需要发邮件问一下吗🥹, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=780c5321661, createdName=Dr Young, createdTime=Sun Mar 10 10:33:22 CST 2024, time=2024-03-10, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1224059, encodeId=8d12122405991, content=18年投过一个被拒，20年打酱油发了一个。最近进入产出低潮。手头只有一个工作想冲击一下，可是疫情影响，很多事情耽误。希望下半年能做完投出去。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=190, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=4fed1686029, createdName=cindichaw, createdTime=Thu Jun 02 15:13:54 CST 2022, time=2022-06-02, status=1, ipAttribution=)]

2021-12-29 MS54455111222

文章题目有没有撰写模板？

204 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=833222, encodeId=c5198332220d, content=要求比较严，英国人还是比较严谨，1270磅版面费，较贵，下次投个汇率低的国家。严格按照编辑意见及审稿人意见修改文章，应该较快，自己补充实验较慢，导致投稿时间较慢，历时10个月，自己浪费了3-5月，大修补充实验2次，小修5次。希望帮到大家。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=306, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=318b5414073, createdName=ms2466276523160074, createdTime=Fri Aug 19 12:01:15 CST 2016, time=2016-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=957032, encodeId=c03195e03209, content=南京鼓楼医院孙倍成教授今年联合国外学者发了一篇关于胰腺癌的文章，他是搞肝移植的啊！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=219, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/PiajxSqBRaEKbUQVcNicMmoEngbhNsjHtgPVly9ibpH1ngtTSp4EjBLr38AKWnRaGSJRVPTfjNL7rlfd969jibvZaw/132, createdBy=793b1668391, createdName=darktempler, createdTime=Wed Apr 14 19:50:27 CST 2021, time=2021-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2097331, encodeId=f648209e331a9, content=偏重的研究方向：肿瘤学;肿瘤 经验分享：集团队重点力量，耗时三年，肿瘤免疫领域，终于发表一篇该期刊。以往都是秒拒，难度还是相当大, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=135, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210104/1a4d3d11af7842afadd172a4a59b32f9/66b07e825e8e4455b5099c678c51e0c6.jpg, createdBy=ab332214260, createdName=susu2019, createdTime=Sat Oct 29 19:21:16 CST 2022, time=2022-10-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1091494, encodeId=38681091494e3, content=文章题目有没有撰写模板？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=204, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1091493, encodeId=29a51091493fd, content=撰写文章题目有没有技巧？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=205, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1009794, encodeId=2f231009e9412, content=请问这个提交之后，一般多久就知道要不要送审，还是直接拒掉, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=221, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b9562152670, createdName=132Luux9886, createdTime=Fri Aug 20 18:51:50 CST 2021, time=2021-08-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=558726, encodeId=597c558e268d, content=CNS子刊生物医学类里面最难的就是nature medicine和cancer cell 需要工作量而不是idea好就能支撑的审稿也很严格可以见到很多文章从received到accepted经历了两年多个人不建议投他家如果可以还不如先试试NCBsunliang 2018-06-30 发表:: 啥时候也来一篇呢.好杂志.不容错过, beContent=sunliang 2018-06-30 发表:: 啥时候也来一篇呢.好杂志.不容错过, objectType=tool_impact_factor, channel=null, level=null, likeNumber=591, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f8eb1668018, createdName=bigapple001, createdTime=Sun Jul 01 18:05:00 CST 2018, time=2018-07-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2197531, encodeId=4303219e5317e, content=都在发这杂志，一年几十篇，以后做科研没CC，不好混了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=44ce21017, createdName=lingtao-zd, createdTime=Tue Apr 09 09:18:30 CST 2024, time=2024-04-09, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2192348, encodeId=6f41219234868, content=With editor快20天了，请问有没有人走同样的经历？后面需要发邮件问一下吗🥹, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=780c5321661, createdName=Dr Young, createdTime=Sun Mar 10 10:33:22 CST 2024, time=2024-03-10, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1224059, encodeId=8d12122405991, content=18年投过一个被拒，20年打酱油发了一个。最近进入产出低潮。手头只有一个工作想冲击一下，可是疫情影响，很多事情耽误。希望下半年能做完投出去。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=190, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=4fed1686029, createdName=cindichaw, createdTime=Thu Jun 02 15:13:54 CST 2022, time=2022-06-02, status=1, ipAttribution=)]

2021-12-29 桑晒麦拉

撰写文章题目有没有技巧？

205 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=833222, encodeId=c5198332220d, content=要求比较严，英国人还是比较严谨，1270磅版面费，较贵，下次投个汇率低的国家。严格按照编辑意见及审稿人意见修改文章，应该较快，自己补充实验较慢，导致投稿时间较慢，历时10个月，自己浪费了3-5月，大修补充实验2次，小修5次。希望帮到大家。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=306, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=318b5414073, createdName=ms2466276523160074, createdTime=Fri Aug 19 12:01:15 CST 2016, time=2016-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=957032, encodeId=c03195e03209, content=南京鼓楼医院孙倍成教授今年联合国外学者发了一篇关于胰腺癌的文章，他是搞肝移植的啊！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=219, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/PiajxSqBRaEKbUQVcNicMmoEngbhNsjHtgPVly9ibpH1ngtTSp4EjBLr38AKWnRaGSJRVPTfjNL7rlfd969jibvZaw/132, createdBy=793b1668391, createdName=darktempler, createdTime=Wed Apr 14 19:50:27 CST 2021, time=2021-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2097331, encodeId=f648209e331a9, content=偏重的研究方向：肿瘤学;肿瘤 经验分享：集团队重点力量，耗时三年，肿瘤免疫领域，终于发表一篇该期刊。以往都是秒拒，难度还是相当大, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=135, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210104/1a4d3d11af7842afadd172a4a59b32f9/66b07e825e8e4455b5099c678c51e0c6.jpg, createdBy=ab332214260, createdName=susu2019, createdTime=Sat Oct 29 19:21:16 CST 2022, time=2022-10-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1091494, encodeId=38681091494e3, content=文章题目有没有撰写模板？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=204, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1091493, encodeId=29a51091493fd, content=撰写文章题目有没有技巧？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=205, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1009794, encodeId=2f231009e9412, content=请问这个提交之后，一般多久就知道要不要送审，还是直接拒掉, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=221, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b9562152670, createdName=132Luux9886, createdTime=Fri Aug 20 18:51:50 CST 2021, time=2021-08-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=558726, encodeId=597c558e268d, content=CNS子刊生物医学类里面最难的就是nature medicine和cancer cell 需要工作量而不是idea好就能支撑的审稿也很严格可以见到很多文章从received到accepted经历了两年多个人不建议投他家如果可以还不如先试试NCBsunliang 2018-06-30 发表:: 啥时候也来一篇呢.好杂志.不容错过, beContent=sunliang 2018-06-30 发表:: 啥时候也来一篇呢.好杂志.不容错过, objectType=tool_impact_factor, channel=null, level=null, likeNumber=591, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f8eb1668018, createdName=bigapple001, createdTime=Sun Jul 01 18:05:00 CST 2018, time=2018-07-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2197531, encodeId=4303219e5317e, content=都在发这杂志，一年几十篇，以后做科研没CC，不好混了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=44ce21017, createdName=lingtao-zd, createdTime=Tue Apr 09 09:18:30 CST 2024, time=2024-04-09, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2192348, encodeId=6f41219234868, content=With editor快20天了，请问有没有人走同样的经历？后面需要发邮件问一下吗🥹, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=780c5321661, createdName=Dr Young, createdTime=Sun Mar 10 10:33:22 CST 2024, time=2024-03-10, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1224059, encodeId=8d12122405991, content=18年投过一个被拒，20年打酱油发了一个。最近进入产出低潮。手头只有一个工作想冲击一下，可是疫情影响，很多事情耽误。希望下半年能做完投出去。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=190, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=4fed1686029, createdName=cindichaw, createdTime=Thu Jun 02 15:13:54 CST 2022, time=2022-06-02, status=1, ipAttribution=)]

2021-08-20 132Luux9886

请问这个提交之后，一般多久就知道要不要送审，还是直接拒掉

221 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=833222, encodeId=c5198332220d, content=要求比较严，英国人还是比较严谨，1270磅版面费，较贵，下次投个汇率低的国家。严格按照编辑意见及审稿人意见修改文章，应该较快，自己补充实验较慢，导致投稿时间较慢，历时10个月，自己浪费了3-5月，大修补充实验2次，小修5次。希望帮到大家。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=306, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=318b5414073, createdName=ms2466276523160074, createdTime=Fri Aug 19 12:01:15 CST 2016, time=2016-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=957032, encodeId=c03195e03209, content=南京鼓楼医院孙倍成教授今年联合国外学者发了一篇关于胰腺癌的文章，他是搞肝移植的啊！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=219, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/PiajxSqBRaEKbUQVcNicMmoEngbhNsjHtgPVly9ibpH1ngtTSp4EjBLr38AKWnRaGSJRVPTfjNL7rlfd969jibvZaw/132, createdBy=793b1668391, createdName=darktempler, createdTime=Wed Apr 14 19:50:27 CST 2021, time=2021-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2097331, encodeId=f648209e331a9, content=偏重的研究方向：肿瘤学;肿瘤 经验分享：集团队重点力量，耗时三年，肿瘤免疫领域，终于发表一篇该期刊。以往都是秒拒，难度还是相当大, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=135, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210104/1a4d3d11af7842afadd172a4a59b32f9/66b07e825e8e4455b5099c678c51e0c6.jpg, createdBy=ab332214260, createdName=susu2019, createdTime=Sat Oct 29 19:21:16 CST 2022, time=2022-10-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1091494, encodeId=38681091494e3, content=文章题目有没有撰写模板？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=204, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1091493, encodeId=29a51091493fd, content=撰写文章题目有没有技巧？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=205, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1009794, encodeId=2f231009e9412, content=请问这个提交之后，一般多久就知道要不要送审，还是直接拒掉, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=221, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b9562152670, createdName=132Luux9886, createdTime=Fri Aug 20 18:51:50 CST 2021, time=2021-08-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=558726, encodeId=597c558e268d, content=CNS子刊生物医学类里面最难的就是nature medicine和cancer cell 需要工作量而不是idea好就能支撑的审稿也很严格可以见到很多文章从received到accepted经历了两年多个人不建议投他家如果可以还不如先试试NCBsunliang 2018-06-30 发表:: 啥时候也来一篇呢.好杂志.不容错过, beContent=sunliang 2018-06-30 发表:: 啥时候也来一篇呢.好杂志.不容错过, objectType=tool_impact_factor, channel=null, level=null, likeNumber=591, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f8eb1668018, createdName=bigapple001, createdTime=Sun Jul 01 18:05:00 CST 2018, time=2018-07-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2197531, encodeId=4303219e5317e, content=都在发这杂志，一年几十篇，以后做科研没CC，不好混了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=44ce21017, createdName=lingtao-zd, createdTime=Tue Apr 09 09:18:30 CST 2024, time=2024-04-09, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2192348, encodeId=6f41219234868, content=With editor快20天了，请问有没有人走同样的经历？后面需要发邮件问一下吗🥹, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=780c5321661, createdName=Dr Young, createdTime=Sun Mar 10 10:33:22 CST 2024, time=2024-03-10, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1224059, encodeId=8d12122405991, content=18年投过一个被拒，20年打酱油发了一个。最近进入产出低潮。手头只有一个工作想冲击一下，可是疫情影响，很多事情耽误。希望下半年能做完投出去。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=190, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=4fed1686029, createdName=cindichaw, createdTime=Thu Jun 02 15:13:54 CST 2022, time=2022-06-02, status=1, ipAttribution=)]

2018-07-01 bigapple001

CNS子刊生物医学类里面最难的就是nature medicine和cancer cell 需要工作量而不是idea好就能支撑的审稿也很严格可以见到很多文章从received到accepted经历了两年多个人不建议投他家如果可以还不如先试试NCBsunliang 2018-06-30 发表::
啥时候也来一篇呢.好杂志.不容错过

sunliang 2018-06-30 发表:: 啥时候也来一篇呢.好杂志.不容错过

591 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=833222, encodeId=c5198332220d, content=要求比较严，英国人还是比较严谨，1270磅版面费，较贵，下次投个汇率低的国家。严格按照编辑意见及审稿人意见修改文章，应该较快，自己补充实验较慢，导致投稿时间较慢，历时10个月，自己浪费了3-5月，大修补充实验2次，小修5次。希望帮到大家。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=306, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=318b5414073, createdName=ms2466276523160074, createdTime=Fri Aug 19 12:01:15 CST 2016, time=2016-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=957032, encodeId=c03195e03209, content=南京鼓楼医院孙倍成教授今年联合国外学者发了一篇关于胰腺癌的文章，他是搞肝移植的啊！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=219, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/PiajxSqBRaEKbUQVcNicMmoEngbhNsjHtgPVly9ibpH1ngtTSp4EjBLr38AKWnRaGSJRVPTfjNL7rlfd969jibvZaw/132, createdBy=793b1668391, createdName=darktempler, createdTime=Wed Apr 14 19:50:27 CST 2021, time=2021-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2097331, encodeId=f648209e331a9, content=偏重的研究方向：肿瘤学;肿瘤 经验分享：集团队重点力量，耗时三年，肿瘤免疫领域，终于发表一篇该期刊。以往都是秒拒，难度还是相当大, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=135, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210104/1a4d3d11af7842afadd172a4a59b32f9/66b07e825e8e4455b5099c678c51e0c6.jpg, createdBy=ab332214260, createdName=susu2019, createdTime=Sat Oct 29 19:21:16 CST 2022, time=2022-10-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1091494, encodeId=38681091494e3, content=文章题目有没有撰写模板？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=204, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1091493, encodeId=29a51091493fd, content=撰写文章题目有没有技巧？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=205, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1009794, encodeId=2f231009e9412, content=请问这个提交之后，一般多久就知道要不要送审，还是直接拒掉, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=221, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b9562152670, createdName=132Luux9886, createdTime=Fri Aug 20 18:51:50 CST 2021, time=2021-08-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=558726, encodeId=597c558e268d, content=CNS子刊生物医学类里面最难的就是nature medicine和cancer cell 需要工作量而不是idea好就能支撑的审稿也很严格可以见到很多文章从received到accepted经历了两年多个人不建议投他家如果可以还不如先试试NCBsunliang 2018-06-30 发表:: 啥时候也来一篇呢.好杂志.不容错过, beContent=sunliang 2018-06-30 发表:: 啥时候也来一篇呢.好杂志.不容错过, objectType=tool_impact_factor, channel=null, level=null, likeNumber=591, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f8eb1668018, createdName=bigapple001, createdTime=Sun Jul 01 18:05:00 CST 2018, time=2018-07-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2197531, encodeId=4303219e5317e, content=都在发这杂志，一年几十篇，以后做科研没CC，不好混了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=44ce21017, createdName=lingtao-zd, createdTime=Tue Apr 09 09:18:30 CST 2024, time=2024-04-09, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2192348, encodeId=6f41219234868, content=With editor快20天了，请问有没有人走同样的经历？后面需要发邮件问一下吗🥹, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=780c5321661, createdName=Dr Young, createdTime=Sun Mar 10 10:33:22 CST 2024, time=2024-03-10, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1224059, encodeId=8d12122405991, content=18年投过一个被拒，20年打酱油发了一个。最近进入产出低潮。手头只有一个工作想冲击一下，可是疫情影响，很多事情耽误。希望下半年能做完投出去。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=190, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=4fed1686029, createdName=cindichaw, createdTime=Thu Jun 02 15:13:54 CST 2022, time=2022-06-02, status=1, ipAttribution=)]

2024-04-09 lingtao-zd 来自湖北省

都在发这杂志，一年几十篇，以后做科研没CC，不好混了

7 0

[GetPortalCommentsPageByObjectIdResponse(id=833222, encodeId=c5198332220d, content=要求比较严，英国人还是比较严谨，1270磅版面费，较贵，下次投个汇率低的国家。严格按照编辑意见及审稿人意见修改文章，应该较快，自己补充实验较慢，导致投稿时间较慢，历时10个月，自己浪费了3-5月，大修补充实验2次，小修5次。希望帮到大家。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=306, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=318b5414073, createdName=ms2466276523160074, createdTime=Fri Aug 19 12:01:15 CST 2016, time=2016-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=957032, encodeId=c03195e03209, content=南京鼓楼医院孙倍成教授今年联合国外学者发了一篇关于胰腺癌的文章，他是搞肝移植的啊！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=219, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/PiajxSqBRaEKbUQVcNicMmoEngbhNsjHtgPVly9ibpH1ngtTSp4EjBLr38AKWnRaGSJRVPTfjNL7rlfd969jibvZaw/132, createdBy=793b1668391, createdName=darktempler, createdTime=Wed Apr 14 19:50:27 CST 2021, time=2021-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2097331, encodeId=f648209e331a9, content=偏重的研究方向：肿瘤学;肿瘤 经验分享：集团队重点力量，耗时三年，肿瘤免疫领域，终于发表一篇该期刊。以往都是秒拒，难度还是相当大, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=135, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210104/1a4d3d11af7842afadd172a4a59b32f9/66b07e825e8e4455b5099c678c51e0c6.jpg, createdBy=ab332214260, createdName=susu2019, createdTime=Sat Oct 29 19:21:16 CST 2022, time=2022-10-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1091494, encodeId=38681091494e3, content=文章题目有没有撰写模板？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=204, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1091493, encodeId=29a51091493fd, content=撰写文章题目有没有技巧？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=205, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1009794, encodeId=2f231009e9412, content=请问这个提交之后，一般多久就知道要不要送审，还是直接拒掉, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=221, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b9562152670, createdName=132Luux9886, createdTime=Fri Aug 20 18:51:50 CST 2021, time=2021-08-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=558726, encodeId=597c558e268d, content=CNS子刊生物医学类里面最难的就是nature medicine和cancer cell 需要工作量而不是idea好就能支撑的审稿也很严格可以见到很多文章从received到accepted经历了两年多个人不建议投他家如果可以还不如先试试NCBsunliang 2018-06-30 发表:: 啥时候也来一篇呢.好杂志.不容错过, beContent=sunliang 2018-06-30 发表:: 啥时候也来一篇呢.好杂志.不容错过, objectType=tool_impact_factor, channel=null, level=null, likeNumber=591, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f8eb1668018, createdName=bigapple001, createdTime=Sun Jul 01 18:05:00 CST 2018, time=2018-07-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2197531, encodeId=4303219e5317e, content=都在发这杂志，一年几十篇，以后做科研没CC，不好混了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=44ce21017, createdName=lingtao-zd, createdTime=Tue Apr 09 09:18:30 CST 2024, time=2024-04-09, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2192348, encodeId=6f41219234868, content=With editor快20天了，请问有没有人走同样的经历？后面需要发邮件问一下吗🥹, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=780c5321661, createdName=Dr Young, createdTime=Sun Mar 10 10:33:22 CST 2024, time=2024-03-10, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1224059, encodeId=8d12122405991, content=18年投过一个被拒，20年打酱油发了一个。最近进入产出低潮。手头只有一个工作想冲击一下，可是疫情影响，很多事情耽误。希望下半年能做完投出去。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=190, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=4fed1686029, createdName=cindichaw, createdTime=Thu Jun 02 15:13:54 CST 2022, time=2022-06-02, status=1, ipAttribution=)]

2024-03-10 Dr Young 来自北京

With editor快20天了，请问有没有人走同样的经历？后面需要发邮件问一下吗🥹

14 0

[GetPortalCommentsPageByObjectIdResponse(id=833222, encodeId=c5198332220d, content=要求比较严，英国人还是比较严谨，1270磅版面费，较贵，下次投个汇率低的国家。严格按照编辑意见及审稿人意见修改文章，应该较快，自己补充实验较慢，导致投稿时间较慢，历时10个月，自己浪费了3-5月，大修补充实验2次，小修5次。希望帮到大家。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=306, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=318b5414073, createdName=ms2466276523160074, createdTime=Fri Aug 19 12:01:15 CST 2016, time=2016-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=957032, encodeId=c03195e03209, content=南京鼓楼医院孙倍成教授今年联合国外学者发了一篇关于胰腺癌的文章，他是搞肝移植的啊！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=219, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/PiajxSqBRaEKbUQVcNicMmoEngbhNsjHtgPVly9ibpH1ngtTSp4EjBLr38AKWnRaGSJRVPTfjNL7rlfd969jibvZaw/132, createdBy=793b1668391, createdName=darktempler, createdTime=Wed Apr 14 19:50:27 CST 2021, time=2021-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2097331, encodeId=f648209e331a9, content=偏重的研究方向：肿瘤学;肿瘤 经验分享：集团队重点力量，耗时三年，肿瘤免疫领域，终于发表一篇该期刊。以往都是秒拒，难度还是相当大, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=135, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210104/1a4d3d11af7842afadd172a4a59b32f9/66b07e825e8e4455b5099c678c51e0c6.jpg, createdBy=ab332214260, createdName=susu2019, createdTime=Sat Oct 29 19:21:16 CST 2022, time=2022-10-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1091494, encodeId=38681091494e3, content=文章题目有没有撰写模板？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=204, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1091493, encodeId=29a51091493fd, content=撰写文章题目有没有技巧？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=205, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1009794, encodeId=2f231009e9412, content=请问这个提交之后，一般多久就知道要不要送审，还是直接拒掉, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=221, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b9562152670, createdName=132Luux9886, createdTime=Fri Aug 20 18:51:50 CST 2021, time=2021-08-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=558726, encodeId=597c558e268d, content=CNS子刊生物医学类里面最难的就是nature medicine和cancer cell 需要工作量而不是idea好就能支撑的审稿也很严格可以见到很多文章从received到accepted经历了两年多个人不建议投他家如果可以还不如先试试NCBsunliang 2018-06-30 发表:: 啥时候也来一篇呢.好杂志.不容错过, beContent=sunliang 2018-06-30 发表:: 啥时候也来一篇呢.好杂志.不容错过, objectType=tool_impact_factor, channel=null, level=null, likeNumber=591, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f8eb1668018, createdName=bigapple001, createdTime=Sun Jul 01 18:05:00 CST 2018, time=2018-07-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2197531, encodeId=4303219e5317e, content=都在发这杂志，一年几十篇，以后做科研没CC，不好混了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=44ce21017, createdName=lingtao-zd, createdTime=Tue Apr 09 09:18:30 CST 2024, time=2024-04-09, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2192348, encodeId=6f41219234868, content=With editor快20天了，请问有没有人走同样的经历？后面需要发邮件问一下吗🥹, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=780c5321661, createdName=Dr Young, createdTime=Sun Mar 10 10:33:22 CST 2024, time=2024-03-10, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1224059, encodeId=8d12122405991, content=18年投过一个被拒，20年打酱油发了一个。最近进入产出低潮。手头只有一个工作想冲击一下，可是疫情影响，很多事情耽误。希望下半年能做完投出去。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=190, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=4fed1686029, createdName=cindichaw, createdTime=Thu Jun 02 15:13:54 CST 2022, time=2022-06-02, status=1, ipAttribution=)]

2022-06-02 cindichaw

18年投过一个被拒，20年打酱油发了一个。最近进入产出低潮。手头只有一个工作想冲击一下，可是疫情影响，很多事情耽误。希望下半年能做完投出去。

190 0

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务